These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 20738205)

  • 1. Inferring the serotype associated with dengue virus infections on the basis of pre- and postinfection neutralizing antibody titers.
    van Panhuis WG; Gibbons RV; Endy TP; Rothman AL; Srikiatkhachorn A; Nisalak A; Burke DS; Cummings DA
    J Infect Dis; 2010 Oct; 202(7):1002-10. PubMed ID: 20738205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dengue virus neutralizing antibody levels associated with protection from infection in thai cluster studies.
    Buddhari D; Aldstadt J; Endy TP; Srikiatkhachorn A; Thaisomboonsuk B; Klungthong C; Nisalak A; Khuntirat B; Jarman RG; Fernandez S; Thomas SJ; Scott TW; Rothman AL; Yoon IK
    PLoS Negl Trop Dis; 2014 Oct; 8(10):e3230. PubMed ID: 25329173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous quantitation of neutralizing antibodies against all four dengue virus serotypes using optimized reporter virus particles.
    Lingemann M; Amaro-Carambot E; Lamirande EW; Pierson TC; Whitehead SS
    J Virol; 2024 Jul; 98(7):e0068124. PubMed ID: 38953379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in dengue virus plaque reduction neutralization testing: systematic review and pooled analysis.
    Rainwater-Lovett K; Rodriguez-Barraquer I; Cummings DA; Lessler J
    BMC Infect Dis; 2012 Sep; 12():233. PubMed ID: 23020074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotype-specific and cross-reactive neutralizing antibodies induced by dengue virus infection: detection of antibodies with different levels of neutralizing activities against homologous and heterologous genotypes of dengue virus type 2 in common marmosets (Callithrix jacchus).
    Azami NAM; Moi ML; Ami Y; Suzaki Y; Lim CK; Taniguchi S; Saijo M; Takasaki T; Kurane I
    Virol J; 2018 Mar; 15(1):51. PubMed ID: 29587780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralization of Dengue Virus Serotypes by Sera from Dengue-Infected Individuals Is Preferentially Directed to Heterologous Serotypes and Not against the Autologous Serotype Present in Acute Infection.
    Auerswald H; Kann S; Klepsch L; Hülsemann J; Rudnik I; Schreiber S; Buchy P; Schreiber M
    Viruses; 2021 Sep; 13(10):. PubMed ID: 34696387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatial dimensions of dengue virus transmission across interepidemic and epidemic periods in Iquitos, Peru (1999-2003).
    Liebman KA; Stoddard ST; Morrison AC; Rocha C; Minnick S; Sihuincha M; Russell KL; Olson JG; Blair PJ; Watts DM; Kochel T; Scott TW
    PLoS Negl Trop Dis; 2012; 6(2):e1472. PubMed ID: 22363822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination.
    Nivarthi UK; Kose N; Sapparapu G; Widman D; Gallichotte E; Pfaff JM; Doranz BJ; Weiskopf D; Sette A; Durbin AP; Whitehead SS; Baric R; Crowe JE; de Silva AM
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28031369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dengue virus infections in a cohort of schoolchildren from Maracay, Venezuela: a 2-year prospective study.
    Comach G; Blair PJ; Sierra G; Guzman D; Soler M; de Quintana MC; Bracho-Labadie M; Camacho D; Russell KL; Olson JG; Kochel TJ
    Vector Borne Zoonotic Dis; 2009 Feb; 9(1):87-92. PubMed ID: 18788903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plaque reduction neutralization antibody test does not accurately predict protection against dengue infection in Ratchaburi cohort, Thailand.
    Sirivichayakul C; Sabchareon A; Limkittikul K; Yoksan S
    Virol J; 2014 Mar; 11():48. PubMed ID: 24620925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of serum neutralizing antibody response in patients with primary dengue virus type 1 infection].
    Hu D; Li J; Wang D; DI B; Qiu L; Wang Y; Ding X; Che X
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1773-6, 1791. PubMed ID: 23268408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization and validation of a plaque reduction neutralization test for the detection of neutralizing antibodies to four serotypes of dengue virus used in support of dengue vaccine development.
    Timiryasova TM; Bonaparte MI; Luo P; Zedar R; Hu BT; Hildreth SW
    Am J Trop Med Hyg; 2013 May; 88(5):962-970. PubMed ID: 23458954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of three alternative methods to the plaque reduction neutralizing assay for measuring neutralizing antibodies to dengue virus serotype 2.
    Goh VSL; Ang CCW; Low SL; Lee PX; Setoh YX; Wong JCC
    Virol J; 2024 Sep; 21(1):208. PubMed ID: 39227969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dengue virus serotype distribution based on serological evidence in pediatric urban population in Indonesia.
    Sasmono RT; Taurel AF; Prayitno A; Sitompul H; Yohan B; Hayati RF; Bouckenooghe A; Hadinegoro SR; Nealon J
    PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006616. PubMed ID: 29953438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High frequency of pre-existing neutralizing antibody responses in patients with dengue during an outbreak in Central Brazil.
    de Teive E Argolo AF; de Rezende Féres VC; Cordeiro MT; da Silveira LA; Guilarde AO; de Azevedo Marques ET; de Souza WV; Martelli CM
    BMC Infect Dis; 2016 Oct; 16(1):546. PubMed ID: 27717314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotype-specific and cross-reactive neutralizing antibody responses in cynomolgus monkeys after infection with multiple dengue virus serotypes.
    Ito M; Katakai Y; Ono F; Akari H; Mukai RZ; Takasaki T; Kotaki A; Kurane I
    Arch Virol; 2011 Jun; 156(6):1073-7. PubMed ID: 21409446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting the human serum antibody response to secondary dengue virus infections.
    Patel B; Longo P; Miley MJ; Montoya M; Harris E; de Silva AM
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005554. PubMed ID: 28505154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence of neutralizing antibodies to dengue virus serotypes in university students from Tabasco, Mexico].
    Sánchez-Burgos GG; López-Alvarado MA; Castañeda-Desales D; Ruiz-Gómez J; Ramos-Castañeda J
    Salud Publica Mex; 2008; 50(5):362-6. PubMed ID: 18852932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies.
    Tsai WY; Durbin A; Tsai JJ; Hsieh SC; Whitehead S; Wang WK
    J Virol; 2015 Jul; 89(14):7348-62. PubMed ID: 25972550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of a reverse genetic system for studying dengue virus serotype 3 strain variation and neutralization.
    Messer WB; Yount B; Hacker KE; Donaldson EF; Huynh JP; de Silva AM; Baric RS
    PLoS Negl Trop Dis; 2012; 6(2):e1486. PubMed ID: 22389731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.